These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36101800)

  • 1. Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma.
    Zhang L; Gu J; Li Y; Ren Z; Zhang B; Yu Z
    Contrast Media Mol Imaging; 2022; 2022():7130533. PubMed ID: 36101800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
    Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
    Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich C; von Herbay A; Friedrich-Rust M; Kunze G; Becker D; Will U; Kratzer W; Albert FW; Pachmann C; Dirks K; Strunk H; Greis C; Bernatik T
    Ultraschall Med; 2008 Oct; 29(5):499-505. PubMed ID: 19241506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging diagnosis of small hepatocellular carcinoma using ultrasound, contrast-enhanced ultrasound and multislice spiral CT].
    Dai L; Feng XR; Chen YP; Wen WQ; Xu YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1469-71. PubMed ID: 18753090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma.
    Guo X; Tian C; Liu G; Mi X; Gao D
    Biotechnol Genet Eng Rev; 2024 Apr; 40(1):623-637. PubMed ID: 36877612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.
    Schwarze V; Marschner C; Völckers W; Grosu S; Negrão de Figueiredo G; Rübenthaler J; Clevert DA
    J Int Med Res; 2020 Jun; 48(6):300060520930151. PubMed ID: 32529869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
    Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
    Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy Evaluation on the Color Doppler Ultrasound, Multislice Spiral CT Combined with Serum Markers in Diagnosis of Primary Hepatic Carcinoma.
    Zhao X; Xia Y; Li C; Wang D
    Iran J Public Health; 2021 Aug; 50(8):1603-1612. PubMed ID: 34917531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
    Maiwald B; Lobsien D; Kahn T; Stumpp P
    PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative the clinical value of contrast-enhanced ultrasonography, enhancement CT and MRI for diagnosing of liver lesions.
    Zhang G; Liu D
    Clin Hemorheol Microcirc; 2022; 80(3):241-251. PubMed ID: 34958008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT.
    Wei SP; Xu CL; Zhang Q; Zhang QR; Zhao YE; Huang PF; Xie YD; Zhou CS; Tian FL; Yang B
    Abdom Radiol (NY); 2017 Aug; 42(8):2135-2145. PubMed ID: 28331942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
    Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.